Patents
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
02/2000
02/02/2000CN1243505A Benzamidine derivatives
02/02/2000CN1243126A Method for preparing asymmetric lactone
02/02/2000CN1243032A Cyclic carbamide surfactant
02/01/2000US6020491 Monomeric and polymeric cyclic amine and N-halamine compounds
02/01/2000US6020488 Small molecule inhibition of RNA/ligand binding
02/01/2000US6020357 Nitrogen containing heteroaromatics as factor Xa inhibitors
02/01/2000CA2062787C Process for the purification of hemin, a novel hemin derivative and a process for its preparation
01/2000
01/27/2000WO2000003996A1 Imidazole derivatives with biphenylsulfonyl substitution, method for preparing them and their use as a drug or diagnostic agent
01/27/2000WO2000003995A1 Diphenylimidazolines
01/27/2000WO2000003994A2 Biphenylsulfonyl-substituted imidazole derivatives, their preparation process, their use as a drug or diagnostic agent and drug containing them
01/27/2000WO1999058477A3 N-[3-[2-[(2,3-dihydro-1h-inden-2-yl)alkylamino]-ethyl]phenyl carboxamide derivatives, preparation and therapeutic applications
01/27/2000DE19921732A1 New 2-benzoyl-1,3-cyclohexanedione derivatives useful as herbicides, especially for selective weed control in monocot crops, e.g. maize
01/27/2000CA2338059A1 Imidazole derivatives with biphenylsulfonyl substitution, method for preparing them and their use as a drug or diagnostic agent
01/27/2000CA2338039A1 Biphenylsulfonyl-substituted imidazole derivatives, their preparation process, their use as a drug or diagnostic agent and drug containing them
01/27/2000CA2337241A1 Diphenylimidazolines
01/26/2000EP0974584A1 Fused ring compounds, process for producing the same and use thereof
01/26/2000EP0973769A1 Process for preparing eprosartan
01/26/2000EP0973768A1 Azole compounds, their production and their use
01/26/2000EP0973762A2 Olefin polymerization catalysts containing group 8-10 transition metals, bidentate ligands , processes employing such catalysts and polymers obtained therefrom
01/26/2000EP0973748A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
01/26/2000EP0973740A1 Design, synthesis and use of specific polyamide dna-binding ligands
01/26/2000EP0973554A1 Chelating agents
01/26/2000EP0973512A1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
01/26/2000EP0973397A1 Novel fungicide composition containing a 2-imidazoline-5-one
01/26/2000EP0973396A1 A method of treating cancer
01/26/2000EP0973395A1 Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them
01/26/2000EP0973392A1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
01/26/2000EP0626943B1 Bistriazenes as chemotherapeutic agents
01/26/2000CN1242363A Process for producing 1,3-dialkyl-2-imidazolidinone
01/26/2000CN1048719C Novel 7-(substituted)-8-(substituted)-9-(substituted amino)-6-demethyl-6-deoxytetracyclines, prepn. method, their compositions and use thereof
01/25/2000US6018053 By carrying out resolution by separating, concentrating or depleting one of the two enantiomeric forms by forming a salt from the racemic compound of given formula and a chiral nonracemic amino compound
01/25/2000US6018052 Fungicidal optically active 1-(mono-or substituted amino)-2-substituted-4,4-disubstituted-2-imidazolin-5-ones and 5- thiones corresponding
01/25/2000US6018049 Process for the preparation of carbamoylated imidazole derivatives
01/25/2000US6017928 Retroviral protease inhibiting compounds
01/25/2000US6017919 Compounds and pharmaceutical use thereof
01/25/2000CA2001436C Carboxylic acid derivatives
01/20/2000WO2000002881A2 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric g protein
01/20/2000WO2000002863A1 Method for producing carbonyl diimidazoles
01/20/2000WO2000002851A1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
01/20/2000DE19832429A1 New imidazolylmethyl-biphenyl-sulfonylcyanamides, are sodium-dependent bicarbonate/chloride exchanger inhibitors used e.g. for treating cardiovascular disorders such as cardiac infarction
01/20/2000DE19832428A1 New imidazolylmethyl-biphenyl-sulfonylcyanamides, are sodium-dependent bicarbonate/chloride exchanger inhibitors used e.g. for treating cardiovascular disorders such as cardiac infarction
01/20/2000DE19831987A1 New diphenyl-imidazolines, used as insecticides, acaricides or nematocides, e.g. for plant protection, and as ectoparasiticides
01/19/2000EP0972769A1 Novel amide derivatives and medicinal compositions thereof
01/19/2000EP0972768A1 Process for producing optically active imidazole compounds, intermediates for synthesizing the same, and process for producing the same
01/19/2000EP0971909A1 Lta 4? hydrolase inhibitors
01/19/2000EP0971900A1 Benzenesulphonamide derivatives, preparation and application thereof in therapy
01/19/2000EP0971854A1 Novel materials useful as electrolytic solutes
01/19/2000EP0971709A1 Novel compounds useful as neuro-protective agents
01/19/2000EP0672038B1 Herbicides
01/19/2000CN1242005A Process for producing imidazole derivatives
01/19/2000CN1242004A Process for making 2-amino-2-imidazoline, guanidine, and 2-amino-3,4,5,6-tetrahydropyrimidine derivatives
01/19/2000CN1048485C Optical active compound and preparing process thereof
01/18/2000US6015821 Skin, psychological and cardiovascular disorders; anticarcinogenic, antiinflammatory and antidiabetic agents
01/18/2000US6015812 N-(arylsulphonyl)amino acid derivatives having bradykinin receptor affinity
01/13/2000WO2000001682A1 Water-soluble derivatives of paclitaxel, method for producing same and uses thereof
01/13/2000WO2000001679A1 Retinoid-associated receptor regulators
01/13/2000WO2000001674A1 Process for making 1,5-disubstituted imidazoles
01/13/2000WO2000001389A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
01/13/2000WO2000001383A1 Angiogenesis inhibitors
01/13/2000DE19830556A1 Verfahren zur Herstellung von Carbonyldiimidazolen A process for preparing carbonyldiimidazoles
01/13/2000CA2336774A1 Angiogenesis inhibitors
01/13/2000CA2336714A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
01/13/2000CA2336204A1 Water-soluble derivatives of paclitaxel, method for producing same and uses thereof
01/13/2000CA2332178A1 Retinoid-associated receptor function regulating agent
01/13/2000CA2277443A1 Process for the preparation of chiral lactones
01/12/2000EP0971002A1 Mixtures of reactive dyes and their use for dyeing fiber material containing hydroxy and/or carbonamide groups
01/12/2000EP0970140A1 Crosslinked polyaspartate salts and a process for their production
01/12/2000EP0970073A1 Process for preparing eprosartan
01/12/2000EP0970046A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
01/12/2000CN1048240C Process for preparing 7-substed-9-substed. amino-6-demethyl-6-deoxytetracyclines
01/12/2000CN1048159C Method for preparing pharmaceutical composition contg. imidazolyl-alkenoic acid
01/11/2000US6013651 Meta-azacyclic amino benzoic acid compounds and derivatives thereof
01/11/2000US6013649 Bond disorders; autoimmune diseases; antitumor agents
01/11/2000US6013200 Low toxicity corrosion inhibitor
01/11/2000CA2180754C Heteroaryl-substituted deoxy glycero-phosphoethanolamines
01/06/2000WO2000000477A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
01/06/2000WO2000000476A1 Process for preparing oximidazoles
01/06/2000WO2000000473A1 Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them
01/06/2000WO2000000465A1 Hydrazine derivatives
01/06/2000WO1999058505A3 Combinations of protein farnesyltransferase and hmg coa reductase inhibitors and their use to treat cancer
01/06/2000CA2336625A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
01/06/2000CA2335921A1 Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them
01/06/2000CA2335245A1 Hydrazine derivatives
01/05/2000EP0969050A1 Reactive dyestuffs and their use in dyeing and printing fibre materials containing hydroxyle and/or carbonamid groups
01/05/2000EP0968206A1 N-heterocyclic derivatives as nos inhibitors
01/05/2000EP0968198A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR INHIBITING $g(b)-AMYLOID PEPTIDE
01/05/2000EP0968186A1 Improved polyamides for binding in the minor groove of double stranded dna
01/05/2000EP0968182A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
01/05/2000EP0968179A1 N-sulphonyl and n-sulphinyl amino acid amides as microbiocides
01/05/2000CN1048011C Process for preparing 1-phenyl-imidazoline-2,5-dione
01/04/2000US6011068 Carbocyclic-alkyl secondary amines
01/04/2000US6011059 Acyl guanidine sodium/proton exchange inhibitors and method
01/04/2000US6011045 Inhibitors of bone resorption; anticancer agents
12/1999
12/29/1999WO1999055670A3 Imidazol-like products and derivatives
12/29/1999EP0967207A1 Nitrone derivatives, process for their preparation and pharmaceutical compositions containing them
12/29/1999EP0966490A2 Catalyst compositions for the polymerization of olefins
12/29/1999EP0966447A1 Small molecules useful in the treatment of inflammatory disease
12/29/1999EP0966446A1 Bicyclic inhibitors of protein farnesyl transferase
12/29/1999EP0966436A1 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
12/29/1999EP0612314B1 2-pyrazinylethylamine derivatives and their use as pharmaceuticals